Use of Intrathecal Fentanyl and Development of Hyperalgesia in Patients Undergoing Elective Cesarean

NCT ID: NCT02387060

Last Updated: 2015-03-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE4

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-08-31

Study Completion Date

2016-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Opioid analgesic drugs are the main treatment of patients during anesthesia. Although highly effective, their use is not without problems. One is the increasing requirement of these address the same nociceptive stimulus.

Opioid induced hyperalgesia could be an explanation studies in animal models. Through mechanisms where N-methyl-D-aspartate receptors, glutamatergic system disturbances and changes in intracellular calcium regulation involved.

The hyperalgesia induced by intrathecal opioids is controversial. The investigators propose a model study in patients undergoing cesarean section to study the secondary hyperalgesia induced based on the study of nociceptive thresholds with two methods opioids: Von Frey filaments and digital algometer.

If intrathecal fentanyl is used in spinal anesthesia for elective cesarean section, then, an increase in sensitivity will occur. This increase can be measured by von Frey filaments, expressed in increased requirement clinically opioids.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Complications; Cesarean Section

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Caregivers Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

H-Bupivacaine 11.5 mg + fentanyl 25 mcg.

Intrathecal administration of Hyperbaric Bupivacaine 1.5 ml 0.75% plus fentanyl 25 mcg.

Group Type EXPERIMENTAL

H-Bupivacaine

Intervention Type DRUG

Intrathecal administration of hyperbaric bupivacaine 1.5 ml 0.75%

Fentanyl

Intervention Type DRUG

Intrathecal administration of fentanyl 25 mcg

H-Bupivacaine 11.5 mg.

Intrathecal administration of Hyperbaric Bupivacaine 1.5 ml 0.75%

Group Type ACTIVE_COMPARATOR

H-Bupivacaine

Intervention Type DRUG

Intrathecal administration of hyperbaric bupivacaine 1.5 ml 0.75%

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

H-Bupivacaine

Intrathecal administration of hyperbaric bupivacaine 1.5 ml 0.75%

Intervention Type DRUG

Fentanyl

Intrathecal administration of fentanyl 25 mcg

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Hyperbaric bupivacaine

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Pregnant 37 to 41 weeks.
* American Society of Anesthesiologists classificationI or II.
* Between 18 and 40 years.
* Scheduled for elective cesarean section under spinal anesthesia in the Maternity Service of the Clinical Hospital of the Catholic University.

Exclusion Criteria

* Background Of high risk pregnancy. Twin-pregnancy.
* Obesity\> 30 kg / m 2 before pregnancy.
* Background Of psychiatric illness.
* Using Chronic analgesic.
* AllergyDrug used in protocol.
* require General anesthesia during surgery
Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Pontificia Universidad Catolica de Chile

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Luis I Cortinez, MD

Role: STUDY_CHAIR

Ponticia Universidad Católica

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hospital Clinico Pontificia Universidad Catolica

Santiago, Santiago Metropolitan, Chile

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Chile

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Juan Carlos De la Cuadra, MD

Role: CONTACT

+56-2-23543270

Hernan Auad, MD

Role: CONTACT

+56-2-23543270

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Hernan Auad, MD

Role: primary

56982933226

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

13-389

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.